224 related articles for article (PubMed ID: 28283462)
41. Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.
Cracowski JL; Degano B; Chabot F; Labarère J; Schwedhelm E; Monneret D; Iuliano L; Schwebel C; Chaouat A; Reynaud-Gaubert M; Faure P; Maas R; Renversez JC; Cracowski C; Sitbon O; Yaïci A; Simonneau G; Humbert M
Chest; 2012 Oct; 142(4):869-876. PubMed ID: 22406961
[TBL] [Abstract][Full Text] [Related]
42. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
[TBL] [Abstract][Full Text] [Related]
43. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
McLaughlin VV
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005
[TBL] [Abstract][Full Text] [Related]
44. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.
Hoeper MM; Huscher D; Ghofrani HA; Delcroix M; Distler O; Schweiger C; Grunig E; Staehler G; Rosenkranz S; Halank M; Held M; Grohé C; Lange TJ; Behr J; Klose H; Wilkens H; Filusch A; Germann M; Ewert R; Seyfarth HJ; Olsson KM; Opitz CF; Gaine SP; Vizza CD; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Pittrow D
Int J Cardiol; 2013 Sep; 168(2):871-80. PubMed ID: 23164592
[TBL] [Abstract][Full Text] [Related]
45. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.
Channick R; Chin KM; McLaughlin VV; Lammi MR; Zamanian RT; Turricchia S; Ong R; Mitchell L; Kim NH
Cardiol Ther; 2024 Jun; 13(2):315-339. PubMed ID: 38451426
[TBL] [Abstract][Full Text] [Related]
46. Mortality in pulmonary arterial hypertension due to congenital heart disease: Serial changes improve prognostication.
Schuijt MTU; Blok IM; Zwinderman AH; van Riel ACMJ; Schuuring MJ; de Winter RJ; Duijnhouwer AL; van Dijk APJ; Mulder BJM; Bouma BJ
Int J Cardiol; 2017 Sep; 243():449-453. PubMed ID: 28606655
[TBL] [Abstract][Full Text] [Related]
47. Risk assessment and survival of patients with pulmonary hypertension: Multicenter experience in Turkey.
Yaylalı YT; Başarıcı I; Kılıçkıran Avcı B; Meriç M; Sinan ÜY; Şenol H; Küçükoğlu MS; Öngen Z
Anatol J Cardiol; 2019 Jun; 21(6):322-330. PubMed ID: 31142721
[TBL] [Abstract][Full Text] [Related]
48. The prognosis of pulmonary arterial hypertension associated with primary Sjögren's syndrome: a cohort study.
Liu Z; Yang X; Tian Z; Qian J; Wang Q; Zhao J; Huang C; Liu Y; Guo X; Wang H; Lai J; Li M; Zhao Y; Zeng X
Lupus; 2018 Jun; 27(7):1072-1080. PubMed ID: 29419347
[TBL] [Abstract][Full Text] [Related]
49. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
50. Prognostic impact of pulmonary arterial hypertension: a population-based analysis.
Carrington M; Murphy NF; Strange G; Peacock A; McMurray JJ; Stewart S
Int J Cardiol; 2008 Feb; 124(2):183-7. PubMed ID: 17433474
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort.
Shirai Y; Yasuoka H; Okano Y; Takeuchi T; Satoh T; Kuwana M
Rheumatology (Oxford); 2012 Oct; 51(10):1846-54. PubMed ID: 22740623
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension.
Shimony A; Eisenberg MJ; Rudski LG; Schlesinger R; Afilalo J; Joyal D; Dragatakis L; Hirsch A; Boutet K; Fox BD; Langleben D
Am J Cardiol; 2011 Aug; 108(3):460-4. PubMed ID: 21600533
[TBL] [Abstract][Full Text] [Related]
53. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
54. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
55. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
56. Long-term patient survival with idiopathic/heritable pulmonary arterial hypertension treated at a single center in Japan.
Ogawa A; Ejiri K; Matsubara H
Life Sci; 2014 Nov; 118(2):414-9. PubMed ID: 24530872
[TBL] [Abstract][Full Text] [Related]
57. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.
Humbert M; Sitbon O; Yaïci A; Montani D; O'Callaghan DS; Jaïs X; Parent F; Savale L; Natali D; Günther S; Chaouat A; Chabot F; Cordier JF; Habib G; Gressin V; Jing ZC; Souza R; Simonneau G;
Eur Respir J; 2010 Sep; 36(3):549-55. PubMed ID: 20562126
[TBL] [Abstract][Full Text] [Related]
58. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
[TBL] [Abstract][Full Text] [Related]
59. Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Southern Taiwan: A Single-Center 10-Year Longitudinal Observation Cohort.
Wu CH; Lin CY; Hsu CH; Lin SH; Weng CT
Healthcare (Basel); 2021 May; 9(5):. PubMed ID: 34065585
[No Abstract] [Full Text] [Related]
60. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era.
Zhang R; Dai LZ; Xie WP; Yu ZX; Wu BX; Pan L; Yuan P; Jiang X; He J; Humbert M; Jing ZC
Chest; 2011 Aug; 140(2):301-309. PubMed ID: 21330386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
